OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Humoral response to mRNA ‐based COVID ‐19 vaccine in patients with myeloid malignancies
Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, et al.
British Journal of Haematology (2022) Vol. 197, Iss. 6, pp. 691-696
Open Access | Times Cited: 23
Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, et al.
British Journal of Haematology (2022) Vol. 197, Iss. 6, pp. 691-696
Open Access | Times Cited: 23
Showing 23 citing articles:
Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis
Chenghao Ge, Kelei Du, Mingjie Luo, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Chenghao Ge, Kelei Du, Mingjie Luo, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma
Takashi Ishio, Shihori Tsukamoto, Emi Yokoyama, et al.
Annals of Hematology (2023) Vol. 102, Iss. 6, pp. 1421-1431
Open Access | Times Cited: 13
Takashi Ishio, Shihori Tsukamoto, Emi Yokoyama, et al.
Annals of Hematology (2023) Vol. 102, Iss. 6, pp. 1421-1431
Open Access | Times Cited: 13
Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies
Armand N. Yazdani, Nathaniel DeMarco, Parth R. Patel, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 662-662
Open Access | Times Cited: 10
Armand N. Yazdani, Nathaniel DeMarco, Parth R. Patel, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 662-662
Open Access | Times Cited: 10
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 15
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 15
Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia
Lorenza Bellusci, Gabrielle Grubbs, Pragya Srivastava, et al.
Blood (2022) Vol. 139, Iss. 18, pp. 2842-2846
Open Access | Times Cited: 11
Lorenza Bellusci, Gabrielle Grubbs, Pragya Srivastava, et al.
Blood (2022) Vol. 139, Iss. 18, pp. 2842-2846
Open Access | Times Cited: 11
COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 545-545
Open Access | Times Cited: 6
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko, et al.
Biology (2023) Vol. 12, Iss. 4, pp. 545-545
Open Access | Times Cited: 6
Covid-19 in patients with haematological malignancies
Hubert Warda, Katarzyna Skórka, Krzysztof Giannopoulos
Acta Haematologica Polonica (2024) Vol. 55, Iss. 2, pp. 73-89
Open Access | Times Cited: 1
Hubert Warda, Katarzyna Skórka, Krzysztof Giannopoulos
Acta Haematologica Polonica (2024) Vol. 55, Iss. 2, pp. 73-89
Open Access | Times Cited: 1
Booster effect of a third mRNA ‐based COVID ‐19 vaccine dose in patients with myeloid malignancies
Akio Mori, Masahiro Onozawa, Mirei Kobayashi, et al.
Cancer Medicine (2023) Vol. 12, Iss. 16, pp. 16881-16888
Open Access | Times Cited: 3
Akio Mori, Masahiro Onozawa, Mirei Kobayashi, et al.
Cancer Medicine (2023) Vol. 12, Iss. 16, pp. 16881-16888
Open Access | Times Cited: 3
COVID-19 Vaccines and Immunosuppressed Patients With Cancer: Critical Considerations
Naomi Cazeau, Meighan Palazzo, Malvi Savani, et al.
Clinical journal of oncology nursing (2022)
Open Access | Times Cited: 5
Naomi Cazeau, Meighan Palazzo, Malvi Savani, et al.
Clinical journal of oncology nursing (2022)
Open Access | Times Cited: 5
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome
David Helfgott, Sabrina Racine‐Brzostek, Kelsey J. Short, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 64, Iss. 3, pp. 662-670
Open Access | Times Cited: 5
David Helfgott, Sabrina Racine‐Brzostek, Kelsey J. Short, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 64, Iss. 3, pp. 662-670
Open Access | Times Cited: 5
Insights into the Impact of Hesitancy on Cancer Care and COVID-19
Nathan Visweshwar, Juan Felipe Rico, Irmel Ayala, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3115-3115
Open Access | Times Cited: 2
Nathan Visweshwar, Juan Felipe Rico, Irmel Ayala, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3115-3115
Open Access | Times Cited: 2
Tyrosine Kinase Inhibitors Do Not Promote a Decrease in SARS-CoV-2 Anti-Spike IgG after BNT162b2 Vaccination in Chronic Myeloid Leukemia: A Prospective Observational Study
Seiichiro Katagiri, Daigo Akahane, Shunsuke Otsuki, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 4
Seiichiro Katagiri, Daigo Akahane, Shunsuke Otsuki, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1404-1404
Open Access | Times Cited: 4
Humoral response to mRNA ‐based COVID ‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
Akio Mori, Masahiro Onozawa, Mirei Kobayashi, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 627-630
Open Access | Times Cited: 4
Akio Mori, Masahiro Onozawa, Mirei Kobayashi, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 627-630
Open Access | Times Cited: 4
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms
Mirei Kobayashi, Akio Mori, Masahiro Onozawa, et al.
Annals of Hematology (2023) Vol. 102, Iss. 4, pp. 819-827
Open Access | Times Cited: 2
Mirei Kobayashi, Akio Mori, Masahiro Onozawa, et al.
Annals of Hematology (2023) Vol. 102, Iss. 4, pp. 819-827
Open Access | Times Cited: 2
Is COVID vaccine effective in patients with myeloid malignancy?
Moshe Mittelman
British Journal of Haematology (2022) Vol. 197, Iss. 6, pp. 656-658
Open Access | Times Cited: 3
Moshe Mittelman
British Journal of Haematology (2022) Vol. 197, Iss. 6, pp. 656-658
Open Access | Times Cited: 3
Antibody responses to SARS‐CoV ‐2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti‐cancer therapies
Wei Yee Chan, Catherine Zhu, Emilie Sanchez, et al.
British Journal of Haematology (2022) Vol. 198, Iss. 3, pp. 478-481
Open Access | Times Cited: 3
Wei Yee Chan, Catherine Zhu, Emilie Sanchez, et al.
British Journal of Haematology (2022) Vol. 198, Iss. 3, pp. 478-481
Open Access | Times Cited: 3
Immune Response to COVID-19 Vaccination in Hematologic Malignancies: A Mini-Review
Samaneh Keshavarz, Somayeh Keshavarz, Nasrin Ziamajidi, et al.
Chonnam Medical Journal (2023) Vol. 59, Iss. 1, pp. 24-24
Open Access | Times Cited: 1
Samaneh Keshavarz, Somayeh Keshavarz, Nasrin Ziamajidi, et al.
Chonnam Medical Journal (2023) Vol. 59, Iss. 1, pp. 24-24
Open Access | Times Cited: 1
Humoral response to mRNA ‐based COVID ‐19 vaccine in patients with immune thrombocytopenia
Akio Mori, Masahiro Onozawa, Mirei Kobayashi, et al.
British Journal of Haematology (2022) Vol. 200, Iss. 6, pp. 717-721
Open Access | Times Cited: 1
Akio Mori, Masahiro Onozawa, Mirei Kobayashi, et al.
British Journal of Haematology (2022) Vol. 200, Iss. 6, pp. 717-721
Open Access | Times Cited: 1
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
Oscar Borsani, Virginia Valeria Ferretti, Ilaria Carola Casetti, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 2, pp. 100122-100122
Open Access
Oscar Borsani, Virginia Valeria Ferretti, Ilaria Carola Casetti, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 2, pp. 100122-100122
Open Access
Defective T‐cell response to COVID ‐19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes
Justin Loke, Vinit Upasani, Charlotte Gaskell, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 3, pp. 498-503
Closed Access
Justin Loke, Vinit Upasani, Charlotte Gaskell, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 3, pp. 498-503
Closed Access
SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation
Fieke W. Hoff, Suleyman Yasin Goksu, Naveen Premnath, et al.
Acta Medica Academica (2023) Vol. 52, Iss. 1, pp. 30-36
Open Access
Fieke W. Hoff, Suleyman Yasin Goksu, Naveen Premnath, et al.
Acta Medica Academica (2023) Vol. 52, Iss. 1, pp. 30-36
Open Access
Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients.
Hideyuki Nakazawa, Kaoko Sakai, Yuriko Sudo, et al.
Transplant Immunology (2022) Vol. 75, pp. 101713-101713
Open Access
Hideyuki Nakazawa, Kaoko Sakai, Yuriko Sudo, et al.
Transplant Immunology (2022) Vol. 75, pp. 101713-101713
Open Access
